Cargando…
Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis
BACKGROUND: Randomized controlled trials (RCTs) comparing systemic thrombolysis to anticoagulation in intermediate risk pulmonary embolism (PE) have yielded mixed results. A prior meta-analysis on this topic had included studies that used lower than standard dose of thrombolytics and included thromb...
Autores principales: | Mathew, Don, Seelam, Susmitha, Bumrah, Karandeep, Sherif, Akil, Shrestha, Utsav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540330/ https://www.ncbi.nlm.nih.gov/pubmed/37770910 http://dx.doi.org/10.1186/s12872-023-03528-w |
Ejemplares similares
-
Updates in Treatment of Recurrent Clostridium difficile Infection
por: Singh, Tanveer, et al.
Publicado: (2019) -
Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014) -
Mortality and bleeding associated with the management of sub-massive pulmonary embolism: a systematic review and Bayesian network meta-analysis
por: Mathew, Don, et al.
Publicado: (2023) -
Ultrasound-assisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism
por: Schissler, Andrew J., et al.
Publicado: (2018) -
Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis
por: Planer, David, et al.
Publicado: (2023)